Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and

Nigel J Stevenson1, Nollaig M Bourke, Elizabeth J Ryan

  • 1School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. n.stevenson@tcd.ie

FEBS Letters
|April 17, 2013
PubMed

Insights

Hepatitis C virus (HCV) blocks interferon-alpha (IFN-α) treatment by degrading key signaling proteins STAT1 and STAT3. This proteasomal degradation prevents effective anti-viral immunity in infected patients.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Interferon-alpha (IFN-α) therapy is crucial for anti-viral immunity.
  • Hepatitis C virus (HCV) infection often leads to treatment failure, suggesting viral interference with IFN-α signaling.
  • The JAK/STAT pathway is central to IFN-α-mediated immune responses.

Purpose of the Study:

  • To investigate the mechanism by which HCV inhibits IFN-α signaling.
  • To determine the impact of HCV on key components of the IFN-α pathway, specifically STAT1 and STAT3 proteins.

Main Methods:

  • Analysis of STAT1 and STAT3 protein and mRNA levels in immune cells and hepatocytes from HCV-infected patients and HCV-expressing cells.
  • Mechanistic studies involving proteasomal degradation assays and the use of proteasomal inhibitor MG132.

Main Results:

  • STAT1 and STAT3 protein levels were reduced in HCV-infected cells, despite normal mRNA levels.
  • HCV infection led to preferential ubiquitination and proteasomal degradation of STAT3.
  • Inhibition of proteasomal degradation prevented STAT3 loss in the presence of HCV.

Conclusions:

  • Hepatitis C virus actively suppresses IFN-α responses by targeting JAK/STAT pathway components.
  • HCV-induced proteasomal degradation of STAT1 and STAT3 is a key mechanism for immune evasion.
  • Understanding this mechanism offers potential therapeutic strategies against HCV treatment resistance.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...